BioSpace News Archive

Drug Development

Despite Mixed Data, Sinovac’s COVID-19 Vaccine is Second Most Used Globally

Sinovac’s CoronaVac was the first COVID-19 vaccine approved in China for emergency use back in June 2020.

July 8, 2021
·
2 min read
·
Brandon May
Drug Development

Veterinary Drug for COVID-19 Patients? Studies Present Confusing Case

Ivermectin has become a contentious issue as to whether it effectively prevents and treats COVID-19. Several studies suggest it is effective, while others have indicated it is not.

July 8, 2021
·
5 min read
·
Mark Terry
Employer Resources

Prepare Your Company and Employees for Remote Work with This Guide

With the outbreak of the COVID-19 pandemic, companies are transitioning to remote work.

July 8, 2021
·
4 min read
·
Lorenzo Soliman
Drug Development

Global Biotech Announces Results from Phase III Trials for Myeloma Treatment

The study, which compared the same treatment combination to pomalidomide plus dexamethasone covered 495 patients from over a hundred hospitals in 21 countries.

July 8, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Biogen Updates Prescribing Label of Controversial Alzheimer’s Drug

The saga continues for Biogen’s Alzheimer’s drug Aduhelm as the U.S. Food and Drug Administration approved an updated label that emphasizes the disease stages for which the drug was approved.

July 8, 2021
·
2 min read
·
Alex Keown
Business

Agenus Sets Sights on New California Site Near Genentech

Agenus, an immuno-oncology company based out of Lexington, Mass., has purchased a 120-acre plot of land near Genentech’s manufacturing facility in Vacaville, Cali.

July 8, 2021
·
2 min read
·
Brandon May
Business

F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors

F-star Therapeutics, Inc. today announced that it has entered into an exclusive licensing agreement with AstraZeneca plc.

July 8, 2021
·
5 min read
Business

IO Biotech Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer

IO Biotech announced today the appointment of Keith Vendola , M.D., M.B.A., as chief financial officer (“CFO”).

July 8, 2021
·
3 min read
Business

OcuTerra Appoints Richard Lindstrom, M.D., and Sheri Rowen, M.D., to Scientific Advisory Board

OcuTerra Therapeutics, Inc . today announced the appointments of Richard Lindstrom, M.D., and Sheri Rowen, M.D., to its Scientific Advisory Board.

July 8, 2021
·
4 min read
Biotech Bay

ReCode Therapeutics to Present at William Blair Biotech Focus Conference 2021

ReCode Therapeutics today announced that CEO and President, David Lockhart, Ph.D., will participate in a panel discussion on non-viral drug delivery at the upcoming William Blair Biotech Focus Conference 2021 at 2:00 pm Eastern Time on Thursday, July 15, 2021.

July 8, 2021
·
1 min read